Amedisys Inc reports results for the quarter ended December 31 - Earnings Summary

• Amedisys Inc AMED.OQ reported quarterly adjusted earnings of 96 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 94 cents. The mean expectation of thirteen analysts for the quarter was for earnings of $1.05 per share. Wall Street expected results to range from 95 cents to $1.11 per share.

• Revenue rose 4.8% to $598.05 million from a year ago; analysts expected $598.58 million.

• Amedisys Inc's reported EPS for the quarter was a loss of 62 cents​.

• The company reported a quarterly loss of $20.38 million.

• Amedisys Inc shares had risen by 0.8% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 9 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the healthcare facilities & services peer group is also "hold"

Wall Street's median 12-month price target for Amedisys Inc is $101.00

This summary was machine generated from LSEG data February 26 at 10:14 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)